19-11021721-G-A
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The NM_003072.5(SMARCA4):c.2617-4G>A variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000311 in 1,607,008 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Benign (★★).
Frequency
Consequence
NM_003072.5 splice_region, intron
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SMARCA4 | NM_001387283.1 | c.2617-4G>A | splice_region_variant, intron_variant | ENST00000646693.2 | NP_001374212.1 | |||
SMARCA4 | NM_003072.5 | c.2617-4G>A | splice_region_variant, intron_variant | ENST00000344626.10 | NP_003063.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SMARCA4 | ENST00000646693.2 | c.2617-4G>A | splice_region_variant, intron_variant | NM_001387283.1 | ENSP00000495368.1 | |||||
SMARCA4 | ENST00000344626.10 | c.2617-4G>A | splice_region_variant, intron_variant | 1 | NM_003072.5 | ENSP00000343896.4 | ||||
SMARCA4 | ENST00000643549.1 | c.2617-4G>A | splice_region_variant, intron_variant | ENSP00000493975.1 | ||||||
SMARCA4 | ENST00000541122.6 | c.2617-4G>A | splice_region_variant, intron_variant | 5 | ENSP00000445036.2 | |||||
SMARCA4 | ENST00000643296.1 | c.2617-4G>A | splice_region_variant, intron_variant | ENSP00000496635.1 | ||||||
SMARCA4 | ENST00000644737.1 | c.2617-4G>A | splice_region_variant, intron_variant | ENSP00000495548.1 | ||||||
SMARCA4 | ENST00000589677.5 | c.2617-4G>A | splice_region_variant, intron_variant | 5 | ENSP00000464778.1 | |||||
SMARCA4 | ENST00000643995.1 | c.2029-4G>A | splice_region_variant, intron_variant | ENSP00000496004.1 | ||||||
SMARCA4 | ENST00000644963.1 | c.1261-4G>A | splice_region_variant, intron_variant | ENSP00000495599.1 | ||||||
SMARCA4 | ENST00000644065.1 | c.1342-4G>A | splice_region_variant, intron_variant | ENSP00000493615.1 | ||||||
SMARCA4 | ENST00000642350.1 | c.1102-4G>A | splice_region_variant, intron_variant | ENSP00000495355.1 | ||||||
SMARCA4 | ENST00000643857.1 | c.970-4G>A | splice_region_variant, intron_variant | ENSP00000494159.1 |
Frequencies
GnomAD3 genomes AF: 0.0000328 AC: 5AN: 152248Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000134 AC: 32AN: 238728Hom.: 0 AF XY: 0.000139 AC XY: 18AN XY: 129808
GnomAD4 exome AF: 0.0000309 AC: 45AN: 1454642Hom.: 0 Cov.: 31 AF XY: 0.0000318 AC XY: 23AN XY: 723094
GnomAD4 genome AF: 0.0000328 AC: 5AN: 152366Hom.: 0 Cov.: 33 AF XY: 0.0000403 AC XY: 3AN XY: 74508
ClinVar
Submissions by phenotype
Hereditary cancer-predisposing syndrome Benign:2
Benign, criteria provided, single submitter | clinical testing | Ambry Genetics | May 22, 2019 | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Benign, criteria provided, single submitter | curation | Sema4, Sema4 | Aug 25, 2021 | - - |
Intellectual disability, autosomal dominant 16 Benign:1
Benign, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Jul 15, 2021 | - - |
Rhabdoid tumor predisposition syndrome 2 Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 17, 2024 | - - |
not provided Benign:1
Benign, criteria provided, single submitter | clinical testing | Quest Diagnostics Nichols Institute San Juan Capistrano | Sep 18, 2023 | - - |
SMARCA4-related disorder Benign:1
Likely benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Jan 19, 2023 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at